Inventor
Veerle Snoeck
Inventor
Zingem, BE
Overview
Patents· 13 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes22%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07KPeptides16%
A23KFodder9%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for9%
C12NMicroorganisms or enzymes9%
C12RIndexing scheme associated with subclasses c12c - c12q, relating to microorganisms5%
G01NInvestigating or analysing materials by determining their chemical or physical properties4%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests4%
PatentTitleYear
11,059,899Polypeptides that bind glucocorticoid-induced TNFR family-related receptor (GITR)202111,009,511Methods for detecting and/or measuring anti-drug antibodies, in particular treatment-emergent anti-drug antibodies202110,858,418Techniques for predicting, detecting and reducing aspecific protein interference in assays involving immunoglobulin single variable domains202010,668,136Treatment of immune disease by mucosal delivery of antigens using genetically modified 202010,195,269Induction of mucosal tolerance to antigens201910,143,729Treatment of immune disease by mucosal delivery of antigens using genetically modified Lactococcus20189,688,763'Chemokine receptor binding polypeptides'20179,539,291'Induction of mucosal tolerance to antigens'20179,526,750'Induction of mucosal tolerance to antigens'20169,328,174'Chemokine receptor binding polypeptides'20168,748,126'Induction of mucosal tolerance to antigens'20148,524,246'Treatment of immune disease by mucosal delivery of antigents using genetically modified Lactobacillus'20138,398,995'Method of inducing immune tolerance to type I diabetes'2013Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2013–2014Patents assigned to ACTOGENIX NV (3)· patent assignee history
2013–2014Patents assigned to ROTTIERS PIETER (2)· patent assignee history
2013–2021Based in Zingem, BE· patent location history
2016–2020Patents assigned to INTREXON ACTOBIOTICS NV (5)· patent assignee history
2016–2017Patents assigned to NOVARTIS AG (2)· patent assignee history
2020–2021Patents assigned to ABLYNX NV (3)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| INTREXON ACTOBIOTICS NV | 5 | 2016–2020 |
| ABLYNX NV | 3 | 2020–2021 |
| ACTOGENIX NV | 3 | 2013–2014 |
| NOVARTIS AG | 2 | 2016–2017 |
| ROTTIERS PIETER | 2 | 2013–2014 |
Locations
| Location | Patents | Span |
|---|---|---|
| Zingem, BE | 13 | 2013–2021 |